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OBJECTIVE: There is no consensus regarding the most appropriate methods (i.e., the side-by-side versus the
stent-in-stent technique) for placing bilateral stents for malignant hilar biliary obstructions. We aimed to
perform a quantitative review of the published data regarding the clinical efficacy of the side-by-side and stent-
in-stent bilateral drainage techniques for hilar biliary obstructions.
METHODS: A comprehensive search of several databases was conducted and a fixed-effects or random-effects
model was used to pool the data from all of the study end-points.
RESULTS: Four clinical trials were identified. A comparison of the side-by-side and stent-in-stent groups
revealed no significant differences with respect to the rates of successful placement, successful drainage, early
complications, late complications and stent occlusions. There were also no significant inter-group differences in
stent patency and patient survival and no publication bias was observed.
CONCLUSIONS: The performance of the side-by-side technique appears to be similar to that of the stent-in-
stent technique for bilateral drainage in patients with malignant hilar biliary obstructions.
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& INTRODUCTION
Malignant hilar biliary obstruction, which can be caused by
a heterogeneous group of tumors, often has an extremely
poor prognosis. Endoscopic biliary stenting is now a well-
established palliative treatment modality. The current evi-
dence indicates that the performance of metallic stents is
superior to that of plastic stents for hilar tumor palliation
with respect to stent patency, repeat drainage rate and patient
survival (1,2). Endoscopic biliary drainage of malignant hilar
strictures is often more challenging and complex than the
management of distal malignant biliary obstructions.
However, whether it is more appropriate to perform
unilateral versus bilateral stent placements in patients with
malignant hilar strictures is a topic of current debate (1).
Many studies have suggested that bilateral drainage affords
significantly better cumulative stent patency and is asso-
ciated with a reduced potential of developing cholangitis
when compared with unilateral drainage (3). Furthermore, a
recent study suggested that draining more than 50% of the
liver volume, which frequently requires bilateral stent
placements, appears to be an important predictor of drainage
effectiveness in malignant hilar strictures (4). In current
clinical practice, there are two methods of placing bilateral
stents: the side-by-side (SBS) and the stent-in-stent (SIS)
techniques (5). The SBS deployment technique results in the
simultaneous insertion of two parallel metallic stents to drain
the bile ducts of both hepatic lobes (6). In the SIS deployment
technique, after placing the first metallic stent across the hilar
stricture, a second stent is inserted into the undrained contra-
lateral hepatic duct through the mesh of the first stent (7). To
date, no consensus has been reached regarding the preferred
method, but several comparative studies on this topic have
been published recently (8-11). In the current study, we
aimed to perform a quantitative review of the published data
regarding the clinical efficacy of the SBS and SIS techniques
for achieving bilateral drainage for hilar biliary obstructions.
& MATERIALS AND METHODS
We searched the Medline (via Pubmed) and Embase
databases for all trials that were published between January
1985 and August 2013 comparing bilateral stenting methods
in the treatment of malignant hilar biliary obstructions.
Two individuals independently performed the search,
then reviewed and extracted the relevant data from each
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study according to a pre-specified protocol. The following
data were extracted and pooled wherever possible:
successful insertion, successful drainage, early complica-
tions, late complications, rate of stent occlusions during the
follow up, stent patency and patient survival. Early
complications were defined as those that occurred within
30 days of stent insertion and late complications were
defined as those occurring more than 30 days after stent
insertion (8,9).
The quality of the randomized and nonrandomized
studies was assessed using the Newcastle–Ottawa Scale
(12). Study quality was evaluated by examining three items:
patient selection, the comparability of the two study groups
and the outcome assessments. Studies achieving five or
more stars were considered to be of the highest quality.
The hazard ratios (HRs) and 95% confidence intervals (CIs)
for stent patency were extracted from papers and/or
presentations (13). The weighted mean differences (WMDs)
and 95% CIs were calculated for all continuous outcomes,
whereas odds ratios (ORs) and 95%CIs were calculated for all
dichotomous data. For each outcome, a fixed-effects or
random-effects model was used to pool the data according
to the results of a statistical heterogeneity test. Heterogeneity
between studies was evaluated using x2 and I2 tests.
Publication bias was assessed visually using a funnel plot and
it was assessed statistically bymeans of regression asymmetry
tests (i.e., Egger’s test (14)) and rank correlation tests (i.e.,
Begg’s test (15)). To minimize type 1 error and reduce the
likelihood of false positive results, all analyses were
performed using the intention-to-treat method. Two-tailed
Table 1 - Characteristics of the included studies.
Study N Gender Male/female
Etiology (cancer)
Biliary/gallbladder/others
Bismuth type
I/II/III/IV
Study Quality
(Star Rating)
Law et al. (9) 24 19/5 14/4/6 0/11/3/10 qqqq
Naitoh et al. (8) 52 25/27 18/24/10 6/14/9/23 qqqqq
Kim et al. (11) 41 28/13 24/4/13 2/11/15/13 qqqqqq
Koh et al. (10) 41 41/0 26/9/6 0/3/26/12 qqqq
Figure 1 - A comparison of the successful stent insertion rate (a) and the successful drainage rate (b) between the SBS and SIS groups.
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Figure 2 - A comparison of the early complications (a), late complications (b) and stent occlusions (c) between the SBS and SIS groups.
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p-values less than 0.05 were considered to be statistically
significant for all analyses.
& RESULTS
Study characteristics
The clinical characteristics of the patients in the selected
trials are shown in Table 1. A total of four trials were included
in the current study (8-11). There were 158 patients included
in the meta-analysis and successful bilateral drainage was
recorded in 146 (92.4%) of these patients. Out of this study
sample, 79 patients received stent placements using the SBS
method and 67 received stent placements using the SIS
technique. A short follow up of 97 days was performed in the
study by Law et al. (9), but most other studies followed
patients for the remainder of their lives.
SBS vs. SIS
As shown in Figure 1, no significant differences in the
successful stent insertion rates were observed between the SBS
and SIS groups (OR 0.195; 95% CI, 0.023, 1.652; p=0.799; 2
studies (8,9); I2 =0%) (Figure 1a). The two groups did not differ
significantly in their rates of successful drainage (OR 0.688; 95%
CI, 0.175, 2.71; p=0.617; 4 studies (8-11); I2 = 0%) (Figure 1b).
A comparison of the SBS and SIS groups revealed no
significant differences with respect to early complications
(OR 2.34; 95% CI, 0.54, 10.11; p= 0.738; 2 studies (8,11);
I2 = 0%) or late complications (OR 3.62; 95% CI, 0.90, 14.56;
p= 0.744; 3 studies (8,9,11); I2 = 0%) (Figures 2a and 2b).
During the follow-up period, the stent occlusion rates
observed in the SBS and SIS groups were not significantly
different (OR 0.554; 95% CI, 0.281, 1.091; p= 0.606; 4 studies
(8-11); I2 = 0%) (Figure 2c).
The pooled estimates of the cumulative patency of the
stent did not reach statistical significance (HR=0.811; 95%
CI: 0.486, 1.353; p= 0.187; 3 studies (8,10,11); I2 = 40.3%)
(Figure 3a). As to overall patient survival, the SBS method
was not associated with a statistically significant survival
benefit when compared with SIS (WMD=17.25; 95% CI:
-109.426, 143.921; p=0.790; 2 studies (8,11); I2 = 56.9%)
(Figure 3b).
Publication bias
An analysis of publication bias was performed for all
study endpoints. Neither Egger’s nor Begg’s tests provided
evidence of publication bias. Figure 4 shows the funnel plot
depicting the publication bias analysis of stent occlusion
(Egger’s test, p= 0.216; Begg’s test, p= 0.734).
& DISCUSSION
Although bilateral stent drainage for malignant hilar
biliary obstructions is performed in many academic centers,
Figure 3 - A comparison of stent patency (a) and patient survival (b) between the SBS and SIS groups.
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the deployment of bilateral metal stents can be technically
challenging, even for experienced surgeons. The SIS
deployment technique is made challenging by the require-
ment to dilate the wire mesh for the introduction of a second
stent and for re-intervention through the mesh at the time of
occlusion (16). SBS procedures are limited by difficulties in
passing the stricture, guiding the stent through the available
delivery shafts and the non-dilated common bile duct.
Because of the different limitations of these techniques, Kim
et al. (11) recommended that the selection of bilateral
stenting methods should be based on the features of each
patient, such as the bile duct diameter and the length of the
stenotic segments in the hilar region. Law et al. (9) also
reported that both techniques are viable and safe but that
success using either technique could be dependent on the
operator and on proper treatment selection. Our data
revealed no significant differences between the SBS and
SIS groups with respect to the rates of successful placement
or successful drainage. In addition, no heterogeneity was
observed. These results are in accordance with the results of
several previous comparative studies (8-11).
Cholecystitis, cholangitis, tumor in-growth and tumor
over-growth are common complications of bilateral stent-
ing. The stent mesh in the hilar region is often larger for SIS
deployments than for SBS deployments, a feature that more
easily allows for tumor in-growth. However, SBS deploy-
ments often increase the diameter of the bile duct by the
parallel stents, thus causing portal vein occlusions (11). The
present study revealed no significant differences between
these groups with respect to the rate of early complications,
late complications or stent occlusions during the follow-up
period. In addition, no heterogeneity was observed.
The median stent patency observed in the SIS and SBS
procedures ranged from 61 (10) to 155 days (8). The median
survival time of patients treated with the SIS and SBS
procedures ranged between 38 (10) and 198 days (8). As
expected, we also found no significant group differences in
stent patency or patient survival. However, it should be
emphasized that these findings exhibited marked hetero-
geneity and should be interpreted with caution. The
heterogeneity of our results may result, at least in part,
from the fact that different individual trials included
different percentages of cholangiocarcinoma. Therefore, in
the future, it will be interesting and necessary to analyze
stent and patient survival for SIS versus SBS procedures in
patients stratified on the basis of the etiology of their hilar
biliary strictures.
Although we observed no evidence of publication bias,
our meta-analysis has several limitations. For example, the
small number of studies that were included and the
relatively small number of patients prevented a more robust
assessment of heterogeneity and publication bias. In
addition, we included one study (11) in which a percuta-
neous approach to stent placement was used exclusively.
Saleem et al. (17) noted that although insertion complica-
tions differ when stents are placed percutaneously com-
pared with those placed endoscopically, the method of stent
placement does not affect the subsequent stent outcome.
Moreover, patients with various disease etiologies were
included; hence, this analysis does not differentiate the
performance of the SBS versus SIS techniques according to
the causes of hilar biliary strictures, thus limiting the
generalizability of these results. Finally, although we
performed an extensive literature and abstract review to
minimize bias in the results, all of the studies examined
were observational in design; thus, the assignment of
patients to the various interventions is subject to selection
bias. In addition, low-quality studies can lead to a distortion
of summary effect estimates.
In conclusion, the performance of the SBS technique
appears to be similar to that of the SIS method for bilateral
drainage in patients with malignant hilar biliary obstruc-
tions. Further prospective control trials with larger sample
sizes are warranted to confirm our conclusions.
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Figure 4 - Begg’s funnel plot for publication bias.
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